AIMS: NADPH oxidase (NOX) 1 but not NOX4-dependent oxidative stress plays a role in diabetic vascular disease, including atherosclerosis. Endothelin (ET)-1 has been implicated in diabetes-induced vascular complications. We showed that crossing mice overexpressing human ET-1 selectively in endothelium (eET-1) with apolipoprotein E knockout (Apoe-/-) mice enhanced high-fat diet-induced atherosclerosis in part by increasing oxidative stress. We tested the hypothesis that ET-1 overexpression in the endothelium would worsen atherosclerosis in type 1 diabetes through a mechanism involving NOX1 but not NOX4. METHODS AND RESULTS: Six-week-old male Apoe-/- and eET-1/Apoe-/- mice with or without Nox1 (Nox1-/y) or Nox4 knockout (Nox4-/-) were injected intraperitoneally with either vehicle or streptozotocin (55 mg/kg/day) for 5 days to induce type 1 diabetes and were studied 14 weeks later. ET-1 overexpression increased 2.5-fold and five-fold the atherosclerotic lesion area in the aortic sinus and arch of diabetic Apoe-/- mice, respectively. Deletion of Nox1 reduced aortic arch plaque size by 60%; in contrast, Nox4 knockout increased lesion size by 1.5-fold. ET-1 overexpression decreased aortic sinus and arch plaque alpha smooth muscle cell content by ∼35% and ∼50%, respectively, which was blunted by Nox1 but not Nox4 knockout. Reactive oxygen species production was increased two-fold in aortic arch perivascular fat of diabetic eET-1/Apoe-/- and eET-1/Apoe-/-/Nox4-/- mice but not eET-1/Apoe-/-/Nox1y/- mice. ET-1 overexpression enhanced monocyte/macrophage and CD3+ T-cell infiltration ∼2.7-fold in the aortic arch perivascular fat of diabetic Apoe-/- mice. Both Nox1 and Nox4 knockout blunted CD3+ T-cell infiltration whereas only Nox1 knockout prevented the monocyte/macrophage infiltration in diabetic eET-1/Apoe-/- mice. CONCLUSION: Endothelium ET-1 overexpression enhances the progression of atherosclerosis in type 1 diabetes, perivascular oxidative stress, and inflammation through NOX1. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: NADPH oxidase (NOX) 1 but not NOX4-dependent oxidative stress plays a role in diabetic vascular disease, including atherosclerosis. Endothelin (ET)-1 has been implicated in diabetes-induced vascular complications. We showed that crossing mice overexpressing human ET-1 selectively in endothelium (eET-1) with apolipoprotein E knockout (Apoe-/-) mice enhanced high-fat diet-induced atherosclerosis in part by increasing oxidative stress. We tested the hypothesis that ET-1 overexpression in the endothelium would worsen atherosclerosis in type 1 diabetes through a mechanism involving NOX1 but not NOX4. METHODS AND RESULTS: Six-week-old male Apoe-/- and eET-1/Apoe-/- mice with or without Nox1 (Nox1-/y) or Nox4 knockout (Nox4-/-) were injected intraperitoneally with either vehicle or streptozotocin (55 mg/kg/day) for 5 days to induce type 1 diabetes and were studied 14 weeks later. ET-1 overexpression increased 2.5-fold and five-fold the atherosclerotic lesion area in the aortic sinus and arch of diabetic Apoe-/- mice, respectively. Deletion of Nox1 reduced aortic arch plaque size by 60%; in contrast, Nox4 knockout increased lesion size by 1.5-fold. ET-1 overexpression decreased aortic sinus and arch plaque alpha smooth muscle cell content by ∼35% and ∼50%, respectively, which was blunted by Nox1 but not Nox4 knockout. Reactive oxygen species production was increased two-fold in aortic arch perivascular fat of diabetic eET-1/Apoe-/- and eET-1/Apoe-/-/Nox4-/- mice but not eET-1/Apoe-/-/Nox1y/- mice. ET-1 overexpression enhanced monocyte/macrophage and CD3+ T-cell infiltration ∼2.7-fold in the aortic arch perivascular fat of diabetic Apoe-/- mice. Both Nox1 and Nox4 knockout blunted CD3+ T-cell infiltration whereas only Nox1 knockout prevented the monocyte/macrophage infiltration in diabetic eET-1/Apoe-/- mice. CONCLUSION: Endothelium ET-1 overexpression enhances the progression of atherosclerosis in type 1 diabetes, perivascular oxidative stress, and inflammation through NOX1. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Andrea L Sheehan; Samuel Carrell; Bryon Johnson; Bojana Stanic; Botond Banfi; Francis J Miller Journal: Atherosclerosis Date: 2011-02-24 Impact factor: 5.162
Authors: Deepesh Pandey; Anand Patel; Vijay Patel; Feng Chen; Jin Qian; Yusi Wang; Scott A Barman; Richard C Venema; David W Stepp; R Daniel Rudic; David J R Fulton Journal: Am J Physiol Heart Circ Physiol Date: 2012-03-16 Impact factor: 4.733
Authors: Lixin Li; Gregory D Fink; Stephanie W Watts; Carrie A Northcott; James J Galligan; Patrick J Pagano; Alex F Chen Journal: Circulation Date: 2003-02-25 Impact factor: 29.690
Authors: Jochen G Schneider; Nicole Tilly; Thomas Hierl; Ulrike Sommer; Andreas Hamann; Klaus Dugi; Gudrun Leidig-Bruckner; Christian Kasperk Journal: Am J Hypertens Date: 2002-11 Impact factor: 2.689
Authors: Stephen P Gray; Elyse Di Marco; Jun Okabe; Cedric Szyndralewiez; Freddy Heitz; Augusto C Montezano; Judy B de Haan; Christine Koulis; Assam El-Osta; Karen L Andrews; Jaye P F Chin-Dusting; Rhian M Touyz; Kirstin Wingler; Mark E Cooper; Harald H H W Schmidt; Karin A Jandeleit-Dahm Journal: Circulation Date: 2013-04-05 Impact factor: 29.690
Authors: Katrin Schröder; Min Zhang; Sebastian Benkhoff; Anja Mieth; Rainer Pliquett; Judith Kosowski; Christoph Kruse; Peter Luedike; U Ruth Michaelis; Norbert Weissmann; Stefanie Dimmeler; Ajay M Shah; Ralf P Brandes Journal: Circ Res Date: 2012-03-27 Impact factor: 17.367